THE DOSE OF MARROW STEM-CELLS INFUSED IS CRITICAL TO REDUCE TRANSPLANT-RELATED MORTALITY (TRM), FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), USING MARROW PURGED BY MAFOSFAMIDE
Nc. Gorin et al., THE DOSE OF MARROW STEM-CELLS INFUSED IS CRITICAL TO REDUCE TRANSPLANT-RELATED MORTALITY (TRM), FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), USING MARROW PURGED BY MAFOSFAMIDE, Bone marrow transplantation, 21, 1998, pp. 10-10